DELUCCIA ROBERT J 4
4 · Acurx Pharmaceuticals, Inc. · Filed Jan 4, 2024
Insider Transaction Report
Form 4
DELUCCIA ROBERT J
Director10% Owner
Transactions
- Gift
Common Stock
2023-12-22−30,000→ 941,198 total - Exercise/Conversion
Common Stock
2024-01-03$3.55/sh+19,737$70,066→ 960,935 total - Gift
Common Stock
2021-12-02−40,000→ 1,011,198 total - Exercise/Conversion
Warrants for Common Stock
2024-01-03−19,737→ 0 totalExercise: $3.55From: 2023-01-27Exp: 2024-01-27→ Common Stock (19,737 underlying) - Gift
Common Stock
2023-12-12−40,000→ 971,198 total
Holdings
- 3,847(indirect: By Spouse)
Common Stock
Footnotes (1)
- [F1]These transactions involved bona fide gifts by the Reporting Person of an aggregate of 110,000 shares of the Issuer's common stock to certain of the Reporting Person's family members who do not share the Reporting Person's household. The Reporting Person disclaims beneficial ownership of the securities held by such family members, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose. These transactions are late due to an inadvertent administrative error and not any error of the Reporting Person.